Neurocrine Biosciences
NBIX
#1290
Rank
$13.71 B
Marketcap
$135.42
Share price
0.34%
Change (1 day)
12.56%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Market capitalization of Neurocrine Biosciences (NBIX)

Market cap: $13.71 Billion USD

As of December 2024 Neurocrine Biosciences has a market cap of $13.71 Billion USD. This makes Neurocrine Biosciences the world's 1290th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Neurocrine Biosciences from 1996 to 2024

End of year Market Cap

Year Marketcap Change
2024$13.71 B5.91%
2023$12.94 B12.74%
2022$11.48 B42.11%
2021$8.07 B-9.78%
2020$8.95 B-9.71%
2019$9.91 B52.97%
2018$6.48 B-5.57%
2017$6.86 B104.23%
2016$3.36 B-31.11%
2015$4.87 B185.67%
2014$1.70 B171.56%
2013$0.62 B26.57%
2012$0.49 B5.82%
2011$0.46 B12.02%
2010$0.41 B250.42%
2009$0.11 B-3.12%
2008$0.12 B-28.92%
2007$0.17 B-56.01%
2006$0.39 B-83.04%
2005$2.32 B29.33%
2004$1.80 B-6.48%
2003$1.92 B37.56%
2002$1.40 B-10.09%
2001$1.55 B85.7%
2000$0.83 B56.8%
1999$0.53 B310.91%
1998$0.13 B-6.56%
1997$0.13 B-24.18%
1996$0.18 B

End of Day market cap according to different sources

On Dec 20th, 2024 the market cap of Neurocrine Biosciences was reported to be:

$13.71 Billion USD
by Yahoo Finance info icon info icon
$13.71 Billion USD
by CompaniesMarketCap info icon info icon
$13.71 Billion USD
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$8.09 B-40.97%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.68 B 7.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
$22.7 M-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$690.45 B 4,935.85%๐Ÿ‡บ๐Ÿ‡ธ USA
$310.27 B 2,162.98%๐Ÿ‡บ๐Ÿ‡ธ USA
$149.38 B 989.51%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.12 B-91.82%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.83 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA